Skip to main content
About the Institute
  • English
  • Français
  • Español

Breadcrumb

  1. Home
  2. Microbiota 6 - March 2019
  3. Resilience of healthy adult gut microbiota following antibiotic exposure
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota 6 - March 2019
  3. Resilience of healthy adult gut microbiota following antibiotic exposure
Gastroenterology

Resilience of healthy adult gut microbiota following antibiotic exposure

Drug

Commented articles - Adults' section

By Pr. Harry Sokol
Gastroenterology and Nutrition, Saint-Antoine Hospital, Paris, France

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

About this article

Created 26 August 2021
Updated 05 January 2022

Comments of the original article of Palleja et al. (Nature Microbiology 2018)

To minimize the impact of antibiotics, gut microorganisms harbour and exchange antibiotics resistance genes, collectively called their resistome. Using shotgun sequencing-based metagenomics, we analysed the partial eradication and subsequent regrowth of the gut microbiota in 12 healthy men over a 6-month period following a 4-day intervention with a cocktail of 3 last-resort antibiotics: meropenem, gentamicin and vancomycin. Initial changes included blooms of enterobacteria and other pathobionts, such as Enterococcus faecalis and Fusobacterium nucleatum, and the depletion of Bifidobacterium species and butyrate producers. The gut microbiota of the subjects recovered to near-baseline composition within 1.5 months, although 9 common species, which were present in all subjects before the treatment, remained undetectable in most of the subjects after 180 days. Species that harbour β-lactam resistance genes were positively selected for during and after the intervention. Harbouring glycopeptide or aminoglycoside resistance genes increased the odds of de novo colonization, however, the former also decreased the odds of survival. Compositional changes under antibiotic intervention in vivo matched results from in vitro susceptibility tests. Despite a mild yet long-lasting imprint following antibiotics exposure, the gut microbiota of healthy young adults are resilient to a short-term broad-spectrum antibiotics intervention and their antibiotics resistance gene carriage modulates their recovery processes.[1]

What is already known about this topic? 

The human gut microbiota forms a complex and balanced ecosystem. Perturbations of this ecosystem can play a role in the development of infections, obesity, diabetes as well as neurological and inflammatory disorders. It is estimated that antibiotics have added 2 to 10 years to our life expectancy, but early exposure to these drugs has also been associated with noxious metabolic, inflammatory and neurological effects, both in animal models and in humans. When microbial communities are exposed to antibiotics, not only do they react by shifting their composition, but also by evolving, optimizing and disseminating antibiotic resistant genes (ABR genes) which collectively form the resistome.[2] The human gut microbiota is a reservoir of ABR genes which are exchanged between the resident strains, thereby propagating resistance.[3] The development and spread of antibiotic-resistant bacteria constitute a serious threat to public health. Only a few studies have investigated the effects of specific antibiotics on intestinal ecosystems and their associated resistomes. In previous work it was shown that antibiotic administration induces a decrease in microbiota diversity and an in- crease in the carriage of ABR genes.[4, 5] However, the effects of a combination of antibiotics on the microbiota and the role of ABR genes in microbial persistence have not yet been studied. In this study, 12 healthy men aged 18 to 40 years received a cocktail of three last-resort antibiotics (vancomycin, gentamicin and meropenem). The authors analysed the impact of this treatment on the gut microbiota by shotgun sequencing of faecal samples taken before and at four time points over a 6-month period following antibiotic administration.

Image

What are the main results of this study? 

At D4, immediately after the intervention, microbiota diversity and richness were notably reduced compared to baseline. However, despite the use of very broad spectrum antibiotics, many species were still detectable at D4 (Figure 1a). By D8, microbiota diversity (measured by the Shan- non index) had considerably increased, suggesting that surviving microorganisms had begun to regrow (Figure 1b). At 6 months, microbiota diversity was almost completely restored to baseline levels but this was not the case for richness, suggesting that some strains had been permanently (or at least extendedly) eradicated.

Some of the early observable changes included blooms of normally subdominant commensals like Escherichia coli, Veillo- nella spp., Klebsiella spp., Enterococcus faecalis and Fusobacterium nucleatum and a sharp depletion of butyrate-producers like Faecalibacterium prausnitzii, Roseburia hominis, Anaerostipes hadrus, Coprococcus spp. and Eubacterium spp. These shifts in microbiota composition were no longer significant at D42.

The authors then investigated the role of ABR genes in microbiota recovery. In particular, they found that β-lactamase-harbouring metagenomic species had significantly higher odds of survival (OR = 1.64 [1.24-2.17]) at D8. In addition, metagenomic species not detected at baseline had better odds of subsequent de novo colonization if they harboured ABR genes against one of the three antibiotic classes used.

Key points

  • The intestinal microbiota of healthy young adults is resilient to 4 days of broad-spectrum antibiotic treatment with an approximate 6-month recovery of most bacterial communities.

  • The recovery of individual species is modulated by ABR gene carriage.

  • The impact of prolonged or repetitive antibiotic treatment requires further study, especially in paediatric populations.

What are the practical consequences? 

These findings indicate that the gut micro- biota of healthy young adults is resilient to a 4-day intervention with broad spectrum antibiotics with recovery of the majority of bacterial communities after about 6 months. The recovery of individual species is modulated by carriage of ABR genes. Further studies are needed to assess the impact of repetitive perturbations and/or over longer periods and to determine whether these findings also hold true in children whose immune system and microbiota are immature. It is possible that repetitive use of antibiotics over long periods selects for bacteria carrying ABR genes at the expense of other commensals, with prolonged or permanent effects on the microbiota. In such cases, corrective intervention with exogenous supply of microorganisms could be considered. The effects of antibiotics on the intestinal microbiota are therefore important and their use must be rationalized.

Conclusion

Broad spectrum antibiotics negatively impact the gut microbiota in an immediate, significant and durable manner for some species. In healthy young adults, the gut microbiota is resilient but near-complete recovery takes about six months. Modulated by ABR gene carriage, the capacity of species to regenerate is more favourable to diversity than to richness.

Sources

1 Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiol 2018 ; 3 : 1255-65.

2 Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 2007 ; 5 : 175-86.

3 van Schaik W. The human gut resistome. Phil Trans R Soc 2015 ; B 370 : 20140087.

4 Rashid MU, Zaura E, Buijs MJ,et al. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods. Clin Infect Dis 2015 ; 60 : S77–S84.

5 Zaura E, Brandt BW, Teixeira de Mattos MJ, et al. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio 2015 ; 6 : e01693-15.

Tags
Gastroenterology

en_view en_sources

    Focus
    Microbiota 6 - March 2019
    • Overview
      • Microbiota and celiac disease
    • Commented articles
      • Resilience of healthy adult gut microbiota following antibiotic exposure
      • Feeding practices from birth to 12 months: impact on the gut microbiota and the risk of being overweight
    • Congress review
      • Fecal transplantation - ready for prime time?
      • The gut microbiota: issues and challenges in the management of metabolic disorders
    • Press review
      • Proton pump inhibitors modify gut microbiome
      • Gut microbiota involved in the pathogenesis of non-alcoholic fatty liver disease
    Created 26 August 2021
    Updated 05 January 2022

    About this article

    To know more about this topic.

    Main topic

    Drug

    Content type

    Commented article
    Microbiota and celiac disease
    Feeding practices from birth to 12 months: impact on the gut microbiota and the risk of being overweight
    Focus

    Microbiota 6 - March 2019

    Overview

    Microbiota and celiac disease

    Commented articles

    Resilience of healthy adult gut microbiota following antibiotic exposure Feeding practices from birth to 12 months: impact on the gut microbiota and the risk of being overweight

    Congress review

    Fecal transplantation - ready for prime time? The gut microbiota: issues and challenges in the management of metabolic disorders

    Press review

    Proton pump inhibitors modify gut microbiome Gut microbiota involved in the pathogenesis of non-alcoholic fatty liver disease
    Gastroenterology
    22.11.2021

    Irritable bowel syndrome: is fecal microbiota transplantation effective in the long term?

    Read the article
    Cancer du pancréas : un diagnostic précoce non invasif grâce au microbiote fécal ?
    16.06.2022

    Pancreatic cancer: non-invasive early diagnosis thanks to the fecal microbiota?

    Read the article
    Photo: Régime méditerranéen « vert » : quels liens entre santé cardiométabolique et microbiote intestinal ?
    10.06.2022

    Green Mediterranean diet: what links between cardiometabolic health and gut microbiota?

    Read the article
    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria
    02.06.2022

    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria

    Read the article
    18.05.2022

    Gut microbiota and vitamin D: a promising team in the fight against osteoporosis?

    Read the article
    Photo: Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
    09.05.2022

    Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal
    22.06.2022

    Postmenopause: the beneficial action of estradiol on the vaginal microbiota

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo